Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled ambroxol hydrochloride for sputum properties in adult lower respiratory tract infections
ChiCTR2200066348Phase 3Completed
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pulmonary infection comparing Treatment group (inhaled ambroxol hydrochloride) with Control group (nebulized saline placebo) (2 arms). Primary endpoint: Sputum property score. Started Mar 2017; status: completed.
02
Drugs
ambroxol
03
Conditions
pulmonary infection
Beyond the preview
Go deeper on ChiCTR2200066348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066348.